Author: Marianne Ryan

factors associated with adverse clinician outcomes

A recent study found that EHR design/use factors, including information overload and excessive data entry, and other factors, such as lack of control of workload, chaotic environments, lack of attention to work-life balance, and ineffective teamwork, significantly contribute to clinician stress and burnout. EDITLife transplant software can help.   The highly-configurable EDITLife Cell Therapy transplant software/Solid Organ transplant software for Data and Workflow Management provides features and...

Read More
integrated systems

For cell therapy clinics and cell therapy labs looking to streamline the flow of information between the clinic and the lab, systems with little or no connectivity are no longer an option. Integrating the clinic and lab ensures that the right users have access to the right data, in the right format, at the right time.   Connectivity between cell therapy clinics and cell therapy labs allows...

Read More

Are you challenged with the demands of CIBMTR form completion and submission, including CAR-T forms? Click here to talk with us about how EDITLife can help.   The EDITLife Team has worked closely with the Center for International Blood and Marrow Transplant Research (CIBMTR) to verify and validate the electronic submission of CAR-T forms and is ready to go!   EDITLife is set to electronically submit all 10 of...

Read More
UNOS TMF 2019

Thanks to everyone who visited the EDITLife booth at UNOS TMF 2019! It was exciting to connect with so many industry leaders. The positive response to EDITLife Solid Organ Transplant- the patient-centric, transplant management software system that efficiently tracks and monitors solid organ transplant-specific data and supplements your EHR - inspired us to work even harder to ensure that EDITLife provides the tools and functionality transplant...

Read More

Searching for the right software vendor, arguably one of the most important administrative decisions that a transplant center makes, can be a daunting task and every program seems to have its own approach.  There are, however, some things that all centers should consider to determine which vendor and solution best fit their needs.   Ability. When you’re choosing a transplant software vendor, you need to know that the...

Read More

Thanks to everyone who stopped by the EDITLife booth at the TCT 2019 Meetings in Houston! We were thrilled to connect with so many industry leaders and with the positive response to EDITLife for Cell Therapy - the patient-centric, transplant management software system that efficiently tracks and monitors BMT-specific data and supplements your EHR. And, we were inspired to work even harder to ensure that...

Read More

See EDITLife at UNOS 2019! MSA is happy to announce that we will be attending the 27th annual UNOS Transplant Management Forum (TMF) 2019, May 13-14, Loews Sapphire Falls Resort in Orlando.   Plan now to stop by Booth #35.  Meet up with our team of experts: Tony Fontecchio, VP, Life Sciences, and Ed Smith, Director, Business Development. See for yourself how EDITLife, a comprehensive, patient-centric, transplant...

Read More

MSA Life Sciences, developers of the EDITLife Transplant Management System (TMS) for Cell Therapy, is pleased to be supporting the 2019 Transplantation and Cellular Therapy (TCT) Meetings. Team leaders will exhibit the state-of-the-art EDITLife clinical workflow application, February 19-23, at the Hilton Americas in Houston, TX.   Something new and exciting this year: the EDITLife team will be hosting helpful educational sessions every day in Booth #2246....

Read More

Thanks to everyone who stopped by the EDITLife booth at NMDP Council Meeting 2018! The conference was a huge success again this year.  We were thrilled to connect with so many industry leaders and overwhelmed by the positive response to EDITLife - the transplant management system (TMS) that streamlines the BMT process! Congratulations to the following lucky raffle winners of the Google Home Minis: Lisa Tyrrell,...

Read More

Findings presented at the American Society of Nephrology's Kidney Week 2018 suggest that gout, a risk factor for serious poor health outcomes, is much more common among solid organ transplant recipients than in the general U.S. population. Using 2016 claims data, researchers found that the prevalence of active gout was 11.3% among solid organ transplant recipients - particularly kidney and heart transplant recipients -  compared...

Read More